Amneal Pharmaceuticals, Inc. AMRX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other noncash income (expense)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other noncash income (expense) of -$1.49M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other noncash income (expense) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other noncash income (expense) decreased by 13.2% year-over-year, from -$1.31M to -$1.49M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other noncash income (expense)?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s other noncash income (expense) has grown at a -4.3% compound annual growth rate (CAGR), from -$5.63M to -$4.73M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.